30
June
2022


Share on networks

The INTEL technology company will open a microchip design laboratory together with the Barcelona Supercomputation Center (BSC-CNS) to help Europe become autonomous in chips with technology based on open-source RISC-V hardware. These chips are used worldwide in the design of autonomous cars or devices for artificial intelligence applications, and their manufacture is crucial, especially in the current context of the supply crisis.

This laboratory will receive an investment from INTEL of 200 million euros over 10 years, plus another 200 million euros from the government. This investment will place the country at the forefront of a key sector of the economy and is expected to generate 300 jobs.

Mateo Valero, director of BSC-CNS, confirmed that the agreement was formalized in Davos between the President of the Government, Pedro Sánchez, and the CEO of Intel, Pat Gelsinger:

In addition, Valero is convinced that the existence of this laboratory in Barcelona, in such a competitive market, where competition is enormous and where Europe does not produce anything, will help to create a hub for new companies and jobs.

Natàlia Mas, Director General of Industry of the Generalitat de Catalunya and Director General of Catalonia Trade & Investment, reaffirms this, pointing out that: “The fact that INTEL is establishing itself in Barcelona with a project as strategic as the microchips is another example of why Catalonia is one of the most dynamic territories in Europe in terms of attracting foreign investment of a technological and productive nature”.

Share on networks

Related news

Llum verda a l’ampliació de l’aeroport del Prat: una inversió de 3.200 milions d’euros per assolir els 70 milions de passatgers

News

El Prat airport expansion gets green light: €3.2 billion to be invested to reach 70 million passengers

Barcelona, entre el ‘top cinc’ dels principals hubs de startups de la Unió Europea per segon any consecutiu

News

Barcelona among top five start-up hubs in European Union for second year in a row

El nou Campus Barcelona de Smith+Nephew consolida Catalunya com a referent de la innovació sanitària a Europa

News

New Smith+Nephew Barcelona Campus consolidates Catalonia as European benchmark in healthcare innovation

Les ciències de la vida a Catalunya es consoliden com a eix d’innovació i creixement: 220 milions d’inversió i 8,7% del PIB

News

Consolidation of life sciences in Catalonia as driving force for innovation and growth: €220 million invested and 8.7% of GDP

Barcelona Catalonia
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.